|
Parameter
|
n
|
SVR
|
Failure SVR
|
p*
|
|---|
| |
216
|
n = 88
|
n = 128
| |
|---|
|
Age (yrs) (mean ± SD)**
| |
51.3 ± 9.7
|
55.2 ± 8.2
|
0.002
|
|
Gender
|
216
| | | |
|
Male
|
123
|
50 (40.7%)
|
73 (59.3%)
|
1.000
|
|
Female
|
93
|
38 (40.9%)
|
55 (59.1%)
| |
|
BMI (Kg/m2)
|
143
| | | |
|
< 30
|
104
|
41 (39.4%)
|
63 (60.6%)
|
0.591
|
|
≥ 30
|
39
|
18 (46.2%)
|
21 (53.8%)
| |
|
Median Aminotrasferase levels, (U/L)***
|
215
|
n = 88
|
n = 127
| |
|
ALT
| |
93 ± 108
|
97 ± 110
|
0.144
|
|
Histological diagnosis****
|
196
| | | |
|
Fibrosis stage 0 – 2
|
47
|
29 (61.7%)
|
18 (38.3%)
|
0.001
|
|
Fibrosis stage 3 – 4
|
149
|
48 (32.2%)
|
101(67.8%)
| |
|
Baseline serum HCV RNA (IU/mL)*****
|
155
| | | |
|
< 800.000
|
55
|
25 (45.5%)
|
30 (54.5%)
|
0.714
|
|
≥ 800.000
|
100
|
41 (41.0%)
|
59 (59%)
| |
- * Significance based on qui-quadrado de Pearson test, t-student and Mann–Whitney.
- **Mean ± standard deviation.
- ***Median (interquartile range).
- ****Twenty missing (9.3%).
- *****Sixty-eight missing (31.5%).
- *****Sixty-one missing (28,2%).
